Confusion about insurance coverage for cervical cancer screenings contributes to missed screening
FODER SOFORTIGE FREIGABE
Kyra Meister
703-836-1746
kyra.meister@preventcancer.org
Alexandria, Va. – Cervical cancer: What was once the leading cause of cancer deaths among women in the U.S. is now one of the most preventable cancers thanks to the human papillomavirus (HPV) vaccine and cervical cancer screening.1 But confusion around the cost of cervical cancer screening is contributing to missed screenings, according to the annual Early Detection Survey from the Prevent Cancer Foundation®. Survey participants cited an inability to afford the cost (29%) as the top reason for not being up to date on their cervical cancer screening.
The 2023 survey shows 41% of American women are not up to date on cervical cancer screenings.2 This indicates an urgent need to discuss the cost of cervical cancer screening, as many people may be unaware cervical cancer screenings are covered through Medicaid and most private insurance plans. Increased understanding of the costs could mean fewer people miss out on essential preventive care.
Insurers are required to cover cervical cancer screenings for anyone with a cervix aged 21-65 because the U.S. Preventive Services Task Force (USPSTF) has issued it an “A” grade. Let’s break that down:
- The USPSTF—a group of medical experts who establish recommendations on certain health services, such as cancer screenings—assign a letter grade (A, B, C, D or I) on whether the services should be performed.
- Per the Affordable Care Act, Medicaid and private insurers are required to cover services, without copay, that are given an “A” or “B” grade.
- That means, under current law, if you have health insurance and you have a cervix, your cervical cancer screenings are covered.
In May 2018, the World Health Organization (WHO) announced a global call for action to eliminate cervical cancer within the next century, with achievable goals to be reached by 2030. While advances towards this goal have been made worldwide, significant disparities exist. The elimination of cervical cancer will be severely hindered without proper education across all populations about screening, insurance coverage and HPV vaccination.
Cervical cancer is most often caused by HPV infection, which can often be prevented with the HPV vaccine. All children should receive the HPV vaccine between ages 9-12. “Catch-up” vaccination is also recommended for teens and young adults up to age 26. If the HPV vaccine is given as recommended, it can prevent more than 90% of HPV-related cancers, including more than 90% of cervical cancers.3 Anyone with a cervix, regardless of vaccination status, should be screened for cervical cancer per recommendations.
People of average risk should follow these guidelines:
From ages 21 to 29: Have a Pap test every 3 years. (With a Pap test, you can find and remove precancerous cells before cancer develops.)
From ages 30 to 65: Have any of these options:
- A Pap test alone every 3 years.
- A high-risk HPV test alone every 5 years.
- A high-risk HPV test with a Pap test (co-testing) every 5 years.
After age 65: Talk with your health care provider about whether you still need to be screened.
If you are at higher risk for cervical cancer because of a suppressed immune system (for example, from HIV infection, organ or stem-cell transplant or long-term steroid use), because you were exposed to DES Wenn Sie bereits im Mutterleib an Gebärmutterhalskrebs erkrankt sind oder wenn Sie bereits an Gebärmutterhalskrebs oder bestimmten Krebsvorstufen erkrankt sind, müssen Sie sich möglicherweise häufiger untersuchen lassen. Befolgen Sie die Empfehlungen Ihres Arztes.
The cost of screening may still be a concern for those who are uninsured. Fortunately, there are free and low-cost screening options available in many communities. Early Detection = Better Outcomes, and everyone deserves an opportunity to check their health and prevent cancer or detect it early.
Information and resources on all cancer types studied in the 2023 Early Detection Survey—including information on relevant screenings—can be found at www.preventcancer.org/betteroutcomes. The Prevent Cancer Foundation will release updated results from the 2024 Early Detection Survey in April. For more information about cervical cancer and ways to reduce your risk, visit www.preventcancer.org/cervical.
1National Center for Chronic Disease Prevention and Health Promotion
2The cancer screenings studied in this survey were for breast cancer, cervical cancer, colorectal cancer, oral cancer, lung cancer, prostate cancer, skin cancer and testicular cancer.
3National Center for Immunization and Respiratory Diseases
###
Über die Prevent Cancer Foundation®
Die Stiftung Prevent Cancer® Ist die einzigen USA-basierend gemeinnützige Organisation einzig und allein gewidmet Zu Krebs Prävention und frühzeitige Erkennung. Durch Forschung, Bildung, Reichweite und Interessenvertretung, Wir haben unzähligen Menschen geholfen, eine Krebsdiagnose zu vermeiden oder ihren Krebs früh genug zu erkennen, um eine erfolgreiche Behandlung zu ermöglichen. Was uns antreibt eine Vision einer Welt, in der Krebs vermeidbar ist, nachweisbarer und schlagbar für alle.
Die Stiftung stellt sich der Herausforderung, die Zahl der Krebstoten bis 2035 um 40% zu senken. Um dieses Ziel zu erreichen, wir sind verpflichtet sich, $20 Millionen in innovative Technologien zur Früherkennung von Krebs und zur Mehr-Krebsvorsorge, $10 Millionen zur Ausweitung des Zugangs zu Krebsvorsorge und Impfungen für medizinisch unterversorgte Gemeinden und $10 Millionen, um die Öffentlichkeit über Screening- und Impfmöglichkeiten aufzuklären.
Für weitere Informationen, besuchen Sie bitte www.preventcancer.org.